ECSP003654A - DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS - Google Patents
DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORSInfo
- Publication number
- ECSP003654A ECSP003654A ECSP003654A ECSP003654A EC SP003654 A ECSP003654 A EC SP003654A EC SP003654 A ECSP003654 A EC SP003654A EC SP003654 A ECSP003654 A EC SP003654A
- Authority
- EC
- Ecuador
- Prior art keywords
- lipasa
- inhibitors
- formulations containing
- dispersion formulations
- dispersion
- Prior art date
Links
- 239000006185 dispersion Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229940086609 Lipase inhibitor Drugs 0.000 abstract 1
- 102000019280 Pancreatic lipases Human genes 0.000 abstract 1
- 108050006759 Pancreatic lipases Proteins 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000004094 surface-active agent Substances 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El presente invento se refiere a composiciones farmacéuticas que comprende por lo menos un inhibidor de lipasas, de preferencia de lipasas gastro-intestinales y pancreáticas, por ejemplo orlistat, por lo menos un tensoactivo y por lo menos un dispersante.The present invention relates to pharmaceutical compositions comprising at least one lipase inhibitor, preferably gastro-intestinal and pancreatic lipases, for example orlistat, at least one surfactant and at least one dispersant.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003654 ECSP003654A (en) | 2000-09-13 | 2000-09-13 | DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003654 ECSP003654A (en) | 2000-09-13 | 2000-09-13 | DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003654A true ECSP003654A (en) | 2001-04-23 |
Family
ID=42041253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003654 ECSP003654A (en) | 2000-09-13 | 2000-09-13 | DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003654A (en) |
-
2000
- 2000-09-13 EC ECSP003654 patent/ECSP003654A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26338A1 (en) | DISPERSIBLE FORMULATIONS CONTAINING LIPASE INHIBITORS | |
| EE200200411A (en) | Pharmaceutical compositions comprising an HMG-CoA reductase inhibitor | |
| UY26860A1 (en) | NEW PHARMACEUTICAL COMPOUND | |
| DE60216448D1 (en) | GRAM-POSITIVE FATTY ACID DERIVATIVES | |
| BRPI0413363A (en) | dosage forms providing controlled release of cholesteryl ester transfer protein inhibitors and immediate release of hmg-coa reductase inhibitors | |
| AU3652102A (en) | Compounds and their uses | |
| AU2001260109A1 (en) | Mixture comprising an inhibitor or suppressor of a gene and molecule binding to an expression product of that gene | |
| UY32116A (en) | A SOLID FORMULATION OF PHARMACEUTICAL DOSAGE | |
| GB2382110A (en) | Clutch assembly | |
| DK1273299T3 (en) | Minoxidilin-containing preparations | |
| TR200200635T2 (en) | Aromatic esters for the labeling or labeling of petroleum products. | |
| JO2242B1 (en) | Phosphatase inhibitors | |
| WO2003057205A3 (en) | Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs | |
| AP1696A (en) | Agrochemical formulations comprising ALS inhibitors. | |
| NZ502133A (en) | Method of enhancing bioavailability of fexofenadine and its derivatives | |
| AU5244101A (en) | Stabilising compositions for lubricating oils | |
| ES2233695T3 (en) | COMPOSITION THAT DELAYS THE GRID. | |
| MXPA03002068A (en) | Creatine ester pronutrient compounds and formulations. | |
| ECSP003654A (en) | DISPERSION FORMULATIONS CONTAINING LIPASA INHIBITORS | |
| AR030593A1 (en) | TENSIOACTIVE SYSTEM | |
| NO20033921L (en) | Monoamine uptake inhibitor | |
| AU2001293944A1 (en) | Method for sulphonylating a hydroxylated organic compound | |
| IL145638A0 (en) | C10 ester substituted taxanes as antitumor agents | |
| ATE317384T1 (en) | LTA4 HYDROLASE INHIBITORS | |
| WO2004012574A3 (en) | Negative selections assays, and compositions thereof |